Main Management ETF Advisors, LLC Rocket Pharmaceuticals, Inc. Transaction History
Main Management ETF Advisors, LLC
- $2.06 Billion
- Q1 2025
A detailed history of Main Management ETF Advisors, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 74,972 shares of RCKT stock, worth $202,424. This represents 0.02% of its overall portfolio holdings.
Number of Shares
74,972
Previous 29,904
150.71%
Holding current value
$202,424
Previous $376,000
32.98%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding RCKT
# of Institutions
258Shares Held
108MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$47.8 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$34.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$17.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$16.7 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$14 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $204M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...